GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BIMI Holdings Inc (STU:63N) » Definitions » Valuation Rank

BIMI Holdings (STU:63N) Valuation Rank


View and export this data going back to . Start your Free Trial

What is BIMI Holdings Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

BIMI Holdings Valuation Rank Related Terms

Thank you for viewing the detailed overview of BIMI Holdings's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

BIMI Holdings (STU:63N) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BIMI Holdings Inc (STU:63N) » Definitions » Valuation Rank
Comparable Companies
RXMD CJJD MEDS HEWA RADCQ PNPL SSY LFLY WBA BSP:RADL3 SHSE:603939 HKSE:00241 TSE:3088 SAU:4164 SHSE:600998 JSE:CLS TSE:3349 TSE:9989 TSE:3391 TSE:3141
Traded in Other Exchanges
BIMI:USA
Address
Chongqing Corporation Avenue, 9th Floor, Building 2, Yuzhong District, Chongqing, CHN, 400010
Website
https://www.usbimi.com
BIMI International Medical Inc is a healthcare product and provider, offering a broad range of healthcare products and related services and operates private hospitals in China. The company is engaged in four business segments, Pharmaceuticals wholesale, Medical devices wholesale, Medical services, and Pharmacy retail. It generates maximum revenue from the pharmaceuticals wholesale segment. It mainly sources its products from large state-owned pharmaceutical manufacturers and wholesalers and mid-sized or small private pharmaceutical manufacturers and wholesalers. The Company's revenues were generated in the PRC.